Abstract

Transdermal Progesterone: Effects on Menopausal Symptoms and on Thrombotic, Anticoagulant, and Inflammatory Factors in Postmenopausal Women

Author(s): Stephenson Kenna, Neuenschwander Pierre F, Kurdowska Anna K, Pinson Barbara, Price Carol

Issue: Jul/Aug 2008 - Hormone Replacement Therapy

Page(s): 295-304

Download in electronic PDF format for $75
  • Transdermal Progesterone: Effects on Menopausal Symptoms and on Thrombotic, Anticoagulant, and Inflammatory Factors in Postmenopausal Women Page 1
  • Transdermal Progesterone: Effects on Menopausal Symptoms and on Thrombotic, Anticoagulant, and Inflammatory Factors in Postmenopausal Women Page 2
  • Transdermal Progesterone: Effects on Menopausal Symptoms and on Thrombotic, Anticoagulant, and Inflammatory Factors in Postmenopausal Women Page 3
  • Transdermal Progesterone: Effects on Menopausal Symptoms and on Thrombotic, Anticoagulant, and Inflammatory Factors in Postmenopausal Women Page 4
  • Transdermal Progesterone: Effects on Menopausal Symptoms and on Thrombotic, Anticoagulant, and Inflammatory Factors in Postmenopausal Women Page 5
  • Transdermal Progesterone: Effects on Menopausal Symptoms and on Thrombotic, Anticoagulant, and Inflammatory Factors in Postmenopausal Women Page 6
  • Transdermal Progesterone: Effects on Menopausal Symptoms and on Thrombotic, Anticoagulant, and Inflammatory Factors in Postmenopausal Women Page 7
  • Transdermal Progesterone: Effects on Menopausal Symptoms and on Thrombotic, Anticoagulant, and Inflammatory Factors in Postmenopausal Women Page 8
  • Transdermal Progesterone: Effects on Menopausal Symptoms and on Thrombotic, Anticoagulant, and Inflammatory Factors in Postmenopausal Women Page 9
  • Transdermal Progesterone: Effects on Menopausal Symptoms and on Thrombotic, Anticoagulant, and Inflammatory Factors in Postmenopausal Women Page 10

Abstract

Conventional hormone replacement therapy increases a woman’s risk of thrombotic events as evidenced in large prospective clinical trials, including HERS I and the Women’s Health Initiative. A possible mechanism for this is the unfavorable net effects of conjugated equine estrogens and medroxyprogesterone acetate on factors involved in hemostatic balance and inflammation. The objective of this study was to examine the short-term effects of transdermal progesterone on menopausal symptoms and serum levels of hemostatic, inflammatory, and immune signaling factors. In a prospective, randomized, double-blinded, placebo-controlled, crossover study, 30 healthy postmenopausal women received either 20 mg/day of transdermal progesterone or placebo for 4 weeks, followed by a 4-week washout period, and were then crossed over to receive either placebo or active drug for an additional 4 weeks. Baseline, 4-week follow-up, and end-of-study values were obtained for the Greene Climacteric Scale, and for serum levels of total fa

Related Keywords

Related Categories

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy
Title/Author
(Click for Abstract / Details / Purchase)
Jul/Aug 2008
Pg. 295-304
Mar/Apr 2003
Pg. 106-113
Author(s): Davidson Gigi S
Jan/Feb 2013
Pg. 74-85
View Sample
Sep/Oct 2003
Pg. 330-338
Jan/Feb 2004
Pg. 16-21
Jan/Feb 2004
Pg. 10-14
Author(s): Preckshot John
Mar/Apr 2004
Pg. 96-99
Sep/Oct 2016
Pg. 359-364
Author(s): Deleruyelle Laura J
Nov/Dec 2016
Pg. 447-454
Author(s): Deleruyelle Laura J
Mar/Apr 2023
Pg. 108-112
Mar/Apr 2010
Pg. 165-170
Jul/Aug 2003
Pg. 250-256
Jan/Feb 2017
Pg. 6-16
Author(s): Deleruyelle Laura J
Jan/Feb 2014
Pg. 70-77
Sep/Oct 1999
Pg. 357-359
Author(s): Reed-Kane Dana
Mar/Apr 2002
Pg. 142-146
Author(s): Wepfer Scott T
Mar/Apr 2012
Pg. 110-114
Nov/Dec 2020
Pg. 466-470
Author(s): DeRosa Angela
Jul/Aug 2007
Pg. 292-296
Jul/Aug 2009
Pg. 345-349